Emerging drugs for sarcopenia: age-related muscle wasting

ISSN： 1472-8214

Source： Expert Opinion on Emerging Drugs, Vol.9, Iss.2, 2004-11, pp. : 345-361

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Update on emerging drugs for sarcopenia – age-related muscle wasting

By Lynch Gordon S

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 4, 2008-12 ,pp. : 655-673

Informa Healthcare

Access to resources Recommend Favorite

Update on therapies for sarcopenia: novel approaches for age-related muscle wasting and weakness

By Lynch Gordon S

Expert Opinion on Therapeutic Patents, Vol. 14, Iss. 9, 2004-09 ,pp. : 1329-1344

Informa Healthcare

Access to resources Recommend Favorite

Novel therapies for sarcopenia: ameliorating age-related changes in skeletal muscle

By Lynch Gordon S

Expert Opinion on Therapeutic Patents, Vol. 12, Iss. 1, 2002-01 ,pp. : 11-27

Informa Healthcare

Access to resources Recommend Favorite

Human Sirtuins: An Overview of an Emerging Drug Target in Age-Related Diseases and Cancer

Current Drug Targets, Vol. 14, Iss. 6, 2013-01 ,pp. : 653-661

Bentham Science Publishers

Access to resources Recommend Favorite

Age-Related Changes in Protein Binding of Drugs: Implications for Therapy

By Grandison M.K. Boudinot F.D.

Clinical Pharmacokinetics, Vol. 38, Iss. 3, 2000-03 ,pp. : 271-290

Adis International

Access to resources Recommend Favorite